middle.news
Radiopharm Theranostics Accelerates Trials with FDA Fast Track and Strong Cash Position
10:13am on Tuesday 29th of July, 2025 AEST
•
Healthcare
Read Story
Radiopharm Theranostics Accelerates Trials with FDA Fast Track and Strong Cash Position
10:13am on Tuesday 29th of July, 2025 AEST
Key Points
FDA grants Fast Track designation for RAD101 brain metastases diagnostic
Dose escalation approved for RAD204 to 60mCi Lutetium-177
Phase 1 HEAT trial of RAD202 underway for HER2-positive tumors
Supply agreements secured for key radioisotopes including Lutetium-177 and Terbium-161
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Radiopharm Theranostics (ASX:RAD)
OPEN ARTICLE